AN2 Therapeutics, Inc.

Grantee website Menlo Park, California, United States
Purpose
to deliver an optimized lead compound for clinical development that can be combined with other compounds to deliver shorter, safer and simpler TB drug regimens
Division
Global Health
Date
SEPTEMBER 2025
Region served
GLOBAL
Committed amount
$1,928,500
Grant topic
Discovery and Translational Sciences
Duration (months)
12
Grantee location
Menlo Park, California, United States

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.